Effective chiral pool synthesis of both enantiomers of the TRPML inhibitor trans-ML-SI3

Arch Pharm (Weinheim). 2022 Feb;355(2):e2100362. doi: 10.1002/ardp.202100362. Epub 2021 Nov 5.

Abstract

Two independent chiral pool syntheses of both enantiomers of the TRPML inhibitor, trans-ML-SI3, were developed, starting from commercially available (1S,2R)- and (1R,2S)-configured cis-2-aminocyclohexanols. Both routes lead to the target compounds in excellent enantiomeric purity and good overall yields. For the most attractive (-)-trans-enantiomer, the R,R-configuration was identified by these unambiguous syntheses, and the results were confirmed by single-crystal X-ray structure analysis. These effective synthetic approaches further allow flexible variation of prominent residues in ML-SI3 for future in-depth analysis of structure-activity relationships as both the piperazine and the N-sulfonyl residues are introduced into the molecule at late stages of the synthesis.

Keywords: TRPML cation channels; arylpiperazine; chiral pool synthesis; enantiomers; sulfamidate.

MeSH terms

  • Cyclohexanols / chemical synthesis
  • Cyclohexanols / chemistry
  • Cyclohexanols / pharmacology*
  • Stereoisomerism
  • Structure-Activity Relationship
  • Transient Receptor Potential Channels / antagonists & inhibitors*

Substances

  • 2-aminocyclohexanol
  • Cyclohexanols
  • Transient Receptor Potential Channels